Condition
Relapsed/Refractory Autoimmune Diseases clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Relapsed/Refractory Autoimmune Diseases clinical trials that are recruiting, in China. By phase: Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
CD19 CAR-T therapy for relapsed or refractory autoimmune diseases
This trial will try CD19 CAR-T cell therapy in adults with relapsed or refractory autoimmune diseases to see if it controls disease activity and allows stopping immunosuppressive drugs.
-
LUCAR-DKS1 for relapsed or treatment-resistant autoimmune diseases
This study will try LUCAR-DKS1, a CAR-NK cell therapy, in adults (18–70) with relapsed or treatment-resistant autoimmune diseases who test positive for CD19 and/or BCMA.
Related topics
Quick answers
How many Relapsed/Refractory Autoimmune Diseases clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.